Source notes

Keeping weight off raises a different biological question from losing it. The paper examines recent research on why weight returns after lifestyle changes, surgery or medication. In one study it discusses, people who stopped semaglutide after 68 weeks regained about two-thirds of their lost weight during the following year. Other work examines lasting changes in fat cells, immune cells, gut microbes and appetite signals. These findings suggest several possible contributors to regain. They do not establish a single cause, and much of the evidence about the underlying processes comes from animals or associations in humans.

A body at a lower weight may still carry changes associated with its previous weight. Some immune changes could favor regain, while others appear to resist it. The relationship between losing fat-free mass and later regain is also inconsistent across studies. These competing findings matter: an appealing biological explanation is not yet proof that targeting that process will improve weight maintenance in people.

How Does This Show Up in Real Life?

Someone who finds maintaining a lower weight difficult may interpret that experience solely as a failure of effort. The evidence gives a more complicated picture, in which appetite and tissue changes can remain relevant after the initial loss. It supports considering maintenance as an ongoing part of obesity care. It does not identify a personal hormone test or microbiome product that will solve regain. For example, an experimental treatment using participants' own stored gut microbes reduced regain only in one dietary group in one trial. That narrow finding cannot support a general claim that changing gut bacteria prevents weight returning. Likewise, the medication-withdrawal example describes a particular study; it does not predict every person's outcome or provide instructions for stopping treatment.

Most proposed mechanisms have limited human intervention evidence. Observing a biological change alongside regain cannot show that the change caused it. Animal experiments may not translate directly to people, and the timing of measurements can alter interpretation. The authors call for studies that distinguish active weight loss from stable reduced weight and follow biological changes over time.

Why We Cite It

Alpekin can use this paper to assess explanations attached to weight-management products. It provides an editorial basis for asking whether a proposed target has actually been tested in people and whether the outcome was sustained maintenance, rather than a laboratory marker presented as a practical breakthrough.

Treat these explanations as developing science. They help put a difficult experience into perspective while leaving important questions open. Confidence should depend on evidence that an intervention changes meaningful outcomes, not simply on how convincing its proposed biological story sounds.